Search for: "American Products Company, Inc" Results 121 - 140 of 4,089
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jul 2023, 8:00 am
COMPANY SUPPOSEDLY DENIED MEDICAL LEAVE TO SENIOR WHO UNDERWENT HEART SURGERYAn Amarillo, Texas, car dealership known as Pete’s Car Smart, Inc., is alleged to have violated federal law because, back in 2021, it denied a long-term employee a medical leave of absence when she underwent bypass heart surgery. [read post]
8 Jul 2023, 4:33 pm by Barry Barnett
 As the 117th Congress neared its end on January 3, 2023, hopes for a slew of ambitious antitrust-reform bills dwindled to just two: the American Innovation and Choice Online Act (AICOA), S. 2992, and the Merger Filing Fee Modernization Act, H.R. 3842. [read post]
5 Jul 2023, 9:30 am by Minyao Wang
It licensed Abitron, a German company, to distribute its products in Europe. [read post]
5 Jul 2023, 3:51 am by Bernard Bell
Chewey, Inc., OSHRC Docket No. 19-0868, 2022 WL 1009607 (February 22, 2022). [read post]
27 Jun 2023, 6:29 am by Unknown
After joining CA100+ in 2000, the letter goes on say that BlackRock used its holdings to force its climate agenda on American utility companies. [read post]
26 Jun 2023, 9:01 pm by renholding
As we reflect on the legacy of Philadelphia National Bank, I hope we can all agree that bank competition is critically important for all Americans. [read post]
25 Jun 2023, 10:54 am by Eugene Volokh
The same applies to boycotts of Israel, or of course of any other countries: An observer who sees a company dealing with a non-Israeli business, and not with an Israeli business, can only perceive a political message when the company accompanies its conduct with speech explaining it.[15] This lack of constitutional protection simply reflects a well-established principle: The First Amendment does not generally protect liberty of contract, whether or not one's choices about whom… [read post]
20 Jun 2023, 8:47 am by admin
Simultaneously, there are several accounts of American companies exploiting workers abroad. [read post]
14 Jun 2023, 9:05 pm by Bryn Hines
Hobby Lobby Stores, Inc. that a company whose owners opposed contraception on religious grounds did not have to provide its employees insurance that covered contraception. [read post]
14 Jun 2023, 8:00 am
Hobby Lobby Stores, Inc., Civil Action No. 22-cv-02258) in U.S. [read post]
12 Jun 2023, 7:08 am by Andrew T. Alessandro
Three large American chemical companies, The Chemours Company, DuPont de Nemours, Inc., and Corteva, Inc., recently announced a massive $1.185 billion settlement deal over complaints about the emerging toxic chemicals of concern known as Per- and Polyfluoroalkyl Substances, or PFAS as they are more commonly referred to. [read post]
12 Jun 2023, 7:08 am by Andrew T. Alessandro
Three large American chemical companies, The Chemours Company, DuPont de Nemours, Inc., and Corteva, Inc., recently announced a massive $1.185 billion settlement deal over complaints about the emerging toxic chemicals of concern known as Per- and Polyfluoroalkyl Substances, or PFAS as they are more commonly referred to. [read post]
12 Jun 2023, 7:08 am by Andrew T. Alessandro
Three large American chemical companies, The Chemours Company, DuPont de Nemours, Inc., and Corteva, Inc., recently announced a massive $1.185 billion settlement deal over complaints about the emerging toxic chemicals of concern known as Per- and Polyfluoroalkyl Substances, or PFAS as they are more commonly referred to. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The  commission believes that Amgen will be able to offer discounts on its existing portfolio of blockbuster products in order to secure quasi-exclusive “preferred placement” on insurance-company formularies, thereby blocking potential rivals to Horizon’s new rare-disease drugs from entering the market. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The  commission believes that Amgen will be able to offer discounts on its existing portfolio of blockbuster products in order to secure quasi-exclusive “preferred placement” on insurance-company formularies, thereby blocking potential rivals to Horizon’s new rare-disease drugs from entering the market. [read post]